Appeals court urged to uphold or block abortion pill ruling by opposing groups and politicians.

Anti-abortion groups are urging a federal appeals court to let the controversial ruling that endangers access to the widely used abortion pill, mifepristone, stand. The ruling invalidates the FDA's 23-year-old approval of the drug, which is part of the standard two-pill regimen for medication abortions. The Biden administration, a coalition of more than 600 drugmakers, biotech leaders, and pharmaceutical advisers, and the Justice Department have condemned the ruling. The court could rule at any time, and Kacsmaryk's ruling is set to go into effect early Saturday barring intervention from the court.